CY1117599T1 - Σουλφοναμιδια για την προληψη του διαβητη - Google Patents

Σουλφοναμιδια για την προληψη του διαβητη

Info

Publication number
CY1117599T1
CY1117599T1 CY20161100375T CY161100375T CY1117599T1 CY 1117599 T1 CY1117599 T1 CY 1117599T1 CY 20161100375 T CY20161100375 T CY 20161100375T CY 161100375 T CY161100375 T CY 161100375T CY 1117599 T1 CY1117599 T1 CY 1117599T1
Authority
CY
Cyprus
Prior art keywords
diabetes
sulfonamides
prevention
medicines
manufacture
Prior art date
Application number
CY20161100375T
Other languages
Greek (el)
English (en)
Inventor
Lorenzo Piemonti
Luisa Daffonchio
Marcello Allegretti
Original Assignee
Dompé Farmaceutici S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dompé Farmaceutici S.P.A. filed Critical Dompé Farmaceutici S.P.A.
Publication of CY1117599T1 publication Critical patent/CY1117599T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
    • C07C311/51—Y being a hydrogen or a carbon atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
CY20161100375T 2009-10-06 2016-05-06 Σουλφοναμιδια για την προληψη του διαβητη CY1117599T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09172365A EP2308485A1 (en) 2009-10-06 2009-10-06 Sulfonamides for the prevention of diabetes
EP10768898.8A EP2485724B1 (en) 2009-10-06 2010-10-06 Sulfonamides for the prevention of diabetes

Publications (1)

Publication Number Publication Date
CY1117599T1 true CY1117599T1 (el) 2017-04-26

Family

ID=41716341

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20161100375T CY1117599T1 (el) 2009-10-06 2016-05-06 Σουλφοναμιδια για την προληψη του διαβητη

Country Status (24)

Country Link
US (2) US8846755B2 (enExample)
EP (2) EP2308485A1 (enExample)
JP (1) JP5745526B2 (enExample)
KR (1) KR101737656B1 (enExample)
CN (1) CN102639128B (enExample)
AU (1) AU2010305384B2 (enExample)
BR (1) BR112012007989B1 (enExample)
CA (1) CA2776021C (enExample)
CY (1) CY1117599T1 (enExample)
DK (1) DK2485724T3 (enExample)
EA (1) EA021788B1 (enExample)
ES (1) ES2570463T3 (enExample)
HR (1) HRP20160399T1 (enExample)
HU (1) HUE028132T2 (enExample)
IL (1) IL219038A (enExample)
ME (1) ME02385B (enExample)
MX (1) MX2012004087A (enExample)
NZ (1) NZ599171A (enExample)
PL (1) PL2485724T3 (enExample)
RS (1) RS54693B1 (enExample)
SI (1) SI2485724T1 (enExample)
SM (1) SMT201600126B (enExample)
WO (1) WO2011042465A1 (enExample)
ZA (1) ZA201202462B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9844528B2 (en) 2006-08-24 2017-12-19 University Of Tennessee Research Foundation SARMs and method of use thereof
EP2308485A1 (en) 2009-10-06 2011-04-13 Dompé S.p.a. Sulfonamides for the prevention of diabetes
EP3281937A1 (en) * 2016-08-09 2018-02-14 Dompé farmaceutici S.p.A. Sulfonamides as gpr40- and gpr120-agonists
WO2018067548A1 (en) 2016-10-03 2018-04-12 The Children's Medicial Center Corporation Prevention and treatment of diabetic nephropathy
EP4686469A1 (en) 2024-07-31 2026-02-04 Dompé farmaceutici SpA Cxcl8 inhibitors for use in the treatment of diabetes-associated comorbidities

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1303249B1 (it) 1998-10-23 2000-11-06 Dompe Spa Alcune n-(2-aril-propionil)-solfonammidi e preparazionifarmaceutiche che le contengono.
ITMI20010206A1 (it) * 2001-02-02 2002-08-02 Dompe Spa Uso della metansolfonammide di (r)-ibuprofene e dei suoi sali non tossici per la preparazione di medicamenti per il trattamento e la prevenz
US20040242498A1 (en) * 2003-02-27 2004-12-02 Collins Tassie L. CXCR3 antagonists
HRP20090681T1 (hr) 2004-03-23 2010-02-28 Dompe' S.P.A. Derivati 2-fenilpropionske kiseline i farmaceutski pripravci koji ih sadrže
DE602004003673T2 (de) 2004-03-25 2007-10-04 Dompe' Pha.R.Ma S.P.A. Verwendung von N-(2-Aryl-propionyl)-sulfonamiden zur Behandlung von Rückenmarkverletzungen
KR20110014141A (ko) * 2008-03-20 2011-02-10 카롤러스 테라퓨틱스, 인코포레이티드 염증을 치료하는 방법
EP2308484A1 (en) * 2009-10-06 2011-04-13 Dompé S.p.a. Inhibitors of cxcr1/2 as adjuvants in the transplant of pancreatic islets
EP2308485A1 (en) 2009-10-06 2011-04-13 Dompé S.p.a. Sulfonamides for the prevention of diabetes

Also Published As

Publication number Publication date
PL2485724T3 (pl) 2016-07-29
BR112012007989B1 (pt) 2019-10-22
SI2485724T1 (sl) 2018-12-31
KR101737656B1 (ko) 2017-05-18
NZ599171A (en) 2014-03-28
AU2010305384A1 (en) 2012-04-26
CA2776021C (en) 2017-08-01
ES2570463T3 (es) 2016-05-18
ZA201202462B (en) 2013-06-26
US20150011639A1 (en) 2015-01-08
US20130059908A1 (en) 2013-03-07
ME02385B (me) 2016-09-20
CA2776021A1 (en) 2011-04-14
US8846755B2 (en) 2014-09-30
US9556115B2 (en) 2017-01-31
EP2485724B1 (en) 2016-02-10
DK2485724T3 (en) 2016-05-02
RS54693B1 (sr) 2016-08-31
CN102639128A (zh) 2012-08-15
IL219038A (en) 2015-07-30
JP2013506703A (ja) 2013-02-28
KR20120083889A (ko) 2012-07-26
SMT201600126B (it) 2016-07-01
AU2010305384B2 (en) 2016-02-04
EA021788B1 (ru) 2015-08-31
EA201270512A1 (ru) 2012-11-30
EP2308485A1 (en) 2011-04-13
CN102639128B (zh) 2014-02-26
EP2485724A1 (en) 2012-08-15
WO2011042465A1 (en) 2011-04-14
JP5745526B2 (ja) 2015-07-08
HRP20160399T1 (hr) 2016-05-20
HUE028132T2 (en) 2016-11-28
MX2012004087A (es) 2012-08-23
IL219038A0 (en) 2012-06-28
HK1174557A1 (en) 2013-06-14

Similar Documents

Publication Publication Date Title
BR112015014562A2 (pt) composições pesticidas e processos com estas relacionados
BRPI0816970A2 (pt) 1,3-dissubstituídas-4-fenil-1h-piridin-2-onas
CY1119953T1 (el) Yποκατεστημενες πυριδοπυραζινες ως προτυποι syk ανοστολεις
CY1112474T1 (el) Πιπεριδινικοι gpcr αγωνιστες
DK2205562T3 (da) 1,1,1-trifluor-2-hydroxy-3-phenylpropanderivater
NO20083694L (no) Bruk av rylener som markorer for vaesker
PH12013502686A1 (en) Pesticidal compositions and processes related thereto
MX355782B (es) Composiciones pesticidas y procesos relacionados a las mismas.
PH12015501394A1 (en) Pesticidal compositions and processes related thereto
ATE555107T1 (de) 2-aza-bicyclo-ä2,2,1-üheptan-derivate
NI201100076A (es) Péptidos antivirales terapéuticos.
BR112015013078A2 (pt) composição compreendendo uma resina de silicone e uma goma de silicone, produtos para cuidados pessoais contendo a mesma
CR11057A (es) Nuevos compuestos heterociclicos nitrogenados, su preparacion y su utilizacion como medicamentos antibacterianos
EP2578587A4 (en) PYRAZOLE DERIVATIVES
UA106880C2 (uk) Нові гербіциди
ATE474886T1 (de) Polythioether-aminharze und zusammensetzungen damit
CL2008000629A1 (es) Compuestos macrociclicos derivados de 6-aril-4-mercapto-[1.3.5]triazina/[1.3]pirimidin-2-amina; composicion farmaceutica, utiles en el tratamiento del cancer.
BRPI0814989A2 (pt) Triazolilpiridina cetonas herbicidas.
TW200700358A (en) Organic compounds
EP2125831A4 (en) ISOFLAVONOID OXAZINYL COMPOUNDS, MEDICAMENTS AND USE
EA201270512A1 (ru) Сульфонамиды для профилактики диабета
ATE518848T1 (de) 3, 6-dihydro-2-oxo-6h-(1,3,4)thiadiazinderivate
EP1915181A4 (en) NEW HIV TARGETS
AP2011005697A0 (en) The 1-butyl-2-hydroxyaralkyl piperazine derivatives and the uses as anti-depression medicine thereof.
CR11449A (es) Productos intermedios gsm